2-(((3S,4R)-4-((3,4-dichlorophenyl)sulfonyl)-1,1-dioxidotetrahydrothiophen-3-yl)amino)ethane-1-sulfonamide

ID: ALA5282987

Max Phase: Preclinical

Molecular Formula: C12H16Cl2N2O6S3

Molecular Weight: 451.38

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NS(=O)(=O)CCN[C@H]1CS(=O)(=O)C[C@@H]1S(=O)(=O)c1ccc(Cl)c(Cl)c1

Standard InChI:  InChI=1S/C12H16Cl2N2O6S3/c13-9-2-1-8(5-10(9)14)25(21,22)12-7-23(17,18)6-11(12)16-3-4-24(15,19)20/h1-2,5,11-12,16H,3-4,6-7H2,(H2,15,19,20)/t11-,12-/m0/s1

Standard InChI Key:  TZYOKZXGKCLYKY-RYUDHWBXSA-N

Molfile:  

 
     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
   -0.6729    0.2248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1520    0.2248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4021   -0.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2512   -1.0498    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9187   -0.5578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0852    0.9391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9100    0.9391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3223    0.2248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1471    0.2248    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.5644    0.9391    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.3891    0.9391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8017    1.6532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6240    1.6524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0364    0.9380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6275    0.2265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8032    0.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8612    0.9380    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.0399   -0.4876    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5644    1.7653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1493    1.3522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6644   -1.7653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1602   -1.7653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5594   -0.4894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1471    1.0511    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8612    0.6387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  1  5  1  0
  5  4  1  0
  1  6  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  2 10  1  1
 10 11  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 11 16  1  0
 14 17  1  0
 15 18  1  0
 10 19  2  0
 10 20  2  0
  4 21  2  0
  4 22  2  0
  9 23  1  0
  9 24  2  0
  9 25  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5282987

    ---

Associated Targets(Human)

NFE2L2 Tchem Nuclear factor erythroid 2-related factor 2 (95332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMR-32 (1082 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.38Molecular Weight (Monoisotopic): 449.9548AlogP: -0.19#Rotatable Bonds: 6
Polar Surface Area: 140.47Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.50CX Basic pKa: 5.87CX LogP: -0.81CX LogD: -0.83
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -1.67

References

1. Jo J, Kim J, Ibrahim L, Kumar M, Iaconelli J, Tran CS, Moon HR, Jung Y, Wiseman RL, Lairson LL, Chatterjee AK, Bollong MJ, Yun H..  (2023)  Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators.,  89  [PMID:37116763] [10.1016/j.bmcl.2023.129306]

Source